Regenerative Medicine Market Is Predicted To Grow Swiftly Due To Increased Prevalence Of Neurodegenerative, Orthopedic & Other Aging-Related Disorders Till 2025: Grand View Research, Inc.
The
global regenerative medicine market size is expected to
reach USD 5.59 billion by 2025, according to a new report by Grand View
Research, Inc. Increased prevalence of neurodegenerative, orthopedic, and other
aging-related disorders in geriatric population coupled with rising global
geriatric population is anticipated to drive market growth.
Developments
in biotechnology have enabled gaining in-depth knowledge pertaining to cell
division and differentiation as well as the metabolism mechanism of various
cells. This enriched knowledge, coupled with emergence of novel streams of
biotechnology such as gene therapy and nanotechnology, further prospered use of
cell-based technology in therapeutic treatment.
Well
established regenerative approached for various dermatological indications
exists since ages. Technological advances introduced scaffolds, matrices, and
grafts engineered for faster regeneration and minimal surgical procedure.
Identification
of ability of stem cells to develop into various different cell lines further
propelled the advancements in regenerative medicine. Frequent media exposure
due to regulatory as well as ethical controversies around embryonic stem cells
has increased awareness among the masses. This encouraged researchers to
explore and develop other potential fields for similar applications, such as
induced pluripotent stem cells (iPSC).
Furthermore,
the emergence of gene therapy techniques with potential to rectify and restore
effects of gene mutations in cells is under development. Conditions caused due
to Single Nucleotide Polymorphism (SNP) as well as mutations that induce
degenerative characteristics are primarily targeted.
Biologics,
individually or in combination with cells or devices, are explored to support
regenerate the biological functions of cells, tissues, or organs. A number of
combinatorial therapies to support chemotherapy and other cancer treatments by
prevention as well as treatment for cancer relapse are in development phases.
In
addition, rising prevalence of complicated degenerative disorders such as
age-related macular degeneration, Alzheimer’s disease, and Parkinson’s disease,
especially in the aging population resulted in high investments in R&D to
develop therapeutic solutions.
Regenerative
medicine grabs the attention of the healthcare industry owing to its promising
applications along with significant advances in supportive fields including
tissue engineering, stem cells, gene therapy, drug discovery and
nanotechnology. For instance, 3D printing over scaffold with stem cells to
restore structure as well as functional characteristics of biological cells,
tissues, and organs.
UK
regenerative medicine market revenue by product type, 2014 - 2025 (USD Million)
Browse full
research report on Regenerative Medicine Market: http://www.grandviewresearch.com/industry-analysis/regenerative-medicine-market
Further
key findings from the report suggest:
- The
global regenerative medicine demand exceeded USD 1.7 billion in 2016 and
is expected to grow at a considerable rate over the forecast period owing
to the presence of a strong looking product pipeline with anticipated
commercializations just around the corner
- Therapeutics
emerged as the largest product segment in 2016 as it has a relatively high
implementation and usage rate resulting in higher adoption
- Global
regenerative services demand for facilities such as tissue banks and
cellular engineering tools is expected to drive demand in the segment
- The
industry in Asia Pacific is projected to witness substantial growth over
the next decade owing to various developments across major economies with
increased focus of dominant players in emerging economies is attributive
to market growth. market.
- Key
players including Asterias Bio, Athersys, Integra LifeSciences
Corpotation, and MiMedx are involved in complex technical cum financial
partnerships with larger players in an attempt to expedite R&D
Browse more
reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the global regenerative medicine market
on the basis of product, therapeutic category, and region:
Regenerative
Medicine Product Outlook (Revenue, USD Million, 2014 - 2025)
- Therapeutics
& Devices
- Primary
Cell-bases therapeutics
- Dermatology
- Musculoskeletal
- Surgical
- Dental
- Others
- Stem
Cell & Progenitor Cell-based therapeutics
- Autologous
- Allogeneic
- Others
- Tools
- Banks
- Services
Regenerative
Medicine Therapeutic Category Outlook (Revenue, USD Million, 2014 - 2025)
- Dermatology
- Musculoskeletal
- Immunology
& Inflammation
- Oncology
- Cardiovascular
- Ophthalmology
- Others
Regenerative
Medicine Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- China
- Japan
- Latin
America
- Brazil
- Middle
East & Africa
- South
Africa
Access
Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-regenerative-medicine-market
About Grand
View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
Comments
Post a Comment